Campylobacter 0:41 isolation in Guillain-barre syndrome

Archives of Disease in Childhood

Volumn 76, Issue 6, 1997, Pages 526-528

  Goddard, E A ^a   Lastovica, A J ^b   Argent, A C ^a,c  

^a Dept of Paediatr and Child Health ^*  (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

Author keywords

Campylobacter jejuni; Guillain Barre syndrome

Indexed keywords

ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CAMPYLOBACTER JEJUNI; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FECES CULTURE; GUILLAIN BARRE SYNDROME; HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0030842073     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.76.6.526     Document Type: Article

References (29)

1. Kaldor J, Speed BR. Guillain-Barré syndrome and Campylobacter jejuni: serological study. BMJ 1984;288:1867-70.
2. Rees JH, Gregson NA, Griffiths PL, et al. Campylobacter jejuni and Guillain-Barré syndrome. Q J Med 1993;86:623-34.
3. De Bont B, Matthews N, Abbott CK, et al. Guillain-Barré syndrome associated with campylobacter enteritis in a child. J Pediatr 1986;109:660-2.
4. Kuroki S, Haruta T, Yoshioka M, et al. Guillain-Barré syndrome associated with campylobacter infection. Pediatr Infect Dis J 1991;10:149-51.
5. Sugita K, Ishii M, Takanashi J, et al. Guillain-Barré syndrome associated with IgM anti-GM1 antibody following Campylobacter jejuni enteritis. Eur J Pediatr 1994;153: 181-3.
6. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27(suppl):S21-4.
7. Skirrow MB, Benjamin J. Differentiation of enteropathogenic campylobacter. J Clin Pathol 1980;33:1122.
8. Penner JL, Hennessy JN, Congi RV. Serotyping of Campylobacter jejuni and campylobacter cold on the basis of thermostable antigens. Eur J Clin Microbiol 1983;2:378-83.
9. Bridgman DHM, Palmer I, Thomas WH, eds. South Africa's leading edge? A guide to the Western Cape economy. Cape Town: Wesgro, 1992.
10. Ropper AH. The Guillain-Barré syndrome. N Engl J Med 1992;329:1130-6.
11. Korinthenberg R, Schulte Monting J. Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study. Arch Dis Child 1996;74:281-7.
12. Briscoe DM, McMenamin JB, O'Donohoe NV. Prognosis in Guillain-Barré syndrome. Arch Dis Child 1987;62:733-5.
13. Cole GF, Matthew DJ. Prognosis in severe Guillain-Barré syndrome. Arch Dis Child 1987;62:288-91.
14. Yuki N, Ichikawa H, Doi A. Fisher syndrome after Campylobacter jejuni enteritis: human leukocyte antigen and the bacterial serotype. J Pediatr 1995;126: 55-7.
15. Rees J, Soudain S, Gregson A, et al. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-9.
16. Mishu B, Ilyas M, Koski CL, et al. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med 1993;118: 947-53.
17. Lastovica AJ, Goddard EA, Argent AC, et al. Guillain-Barré syndrome and Campylobacter jejuni serotype 0:41 infection [abst]. 96th General Meeting of the American Society for Microbiology, 1996: abst C-334.
18. Fujimoto S, Yuki N, Itoh T, et al. Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome. J Infect Dis 1992;165:183.
19. Kuroki S, Saida T, Nukina M, et al. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann Neurol 1993;33:243-7.
20. Enders U, Karch H. Toyka KV, er al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 1993;34:136-44.
21. Vriesendorp FJ, Mishu B, Blaser MJ, et al. Serum antibodies to GMI, GDlb, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol 1993;34: 130-5.
22. Von Wulffen H, Hartard C, Scharein E. Seroreactivity to Campylobacter jejuni and gangliosides in patients with Guillain-Barré syndrome. J Infect Dis 1994;170:823-33.
23. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118: 597-605.
24. Yuki N, Handa S, Taki T, et al. Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barré syndrome: molecular mimicry between ganglioside GM1 and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni. Biomedical Research 1992;13:451-3.
25. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993;178:1771-5.
26. Aspinall GO, Fujimoto S, McDonald AG, et al. Lipopolysaccharide from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immun 1994;62:2122-5.
27. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995;118: 577-95.
28. Ropper AH. Campylobacter diarrhea and Guillain-Barré syndrome. Arch Neurol 1988;45:655-6.
29. Blaser MJ, Reller LB. Campylobacter enteritis. N Engl J Med 1981;305:1444-51.